Open Access Research

Research Increased plasma membrane cholesterol in cystic fibrosis cells correlates with CFTR genotype and depends on de novo cholesterol synthesis Abstract Background: Previous observations demonstrate that Cftr-null cells and tissues exhibit alterations in cholesterol processing including perinuclear cholesterol accumulation, increased de novo synthesis, and an increase in plasma membrane cholesterol accessibility compared to wild type controls. The hypothesis of this study is that membrane cholesterol accessibility correlates with CFTR genotype and is in part influenced by de novo cholesterol synthesis. Methods: Electrochemical detection of cholesterol at the plasma membrane is achieved with capillary microelectrodes with a modified platinum coil that accepts covalent attachment of cholesterol oxidase. Modified electrodes absent cholesterol oxidase serves as a baseline control. Cholesterol synthesis is determined by deuterium incorporation into lipids over time. Incorporation into cholesterol specifically is determined by mass spectrometry analysis. All mice used in the study are on a C57Bl/6 background and are between 6 and 8 weeks of age. Results: Membrane cholesterol measurements are elevated in both R117H and ΔF508 mouse nasal epithelium compared to age-matched sibling wt controls demonstrating a genotype correlation to membrane cholesterol detection. Expression of wt CFTR in CF epithelial cells reverts membrane cholesterol to WT levels further demonstrating the impact of CFTR on these processes. In wt epithelial cell, the addition of the CFTR inhibitors, Gly H101 or CFTR inh-172, for 24 h surprisingly results in an initial drop in membrane cholesterol measurement followed by a rebound at 72 h suggesting a feedback mechanism may be driving the increase in membrane cholesterol. De novo cholesterol synthesis contributes to membrane cholesterol accessibility. Conclusions: The data in this study suggest that CFTR influences cholesterol trafficking to the plasma membrane, which when depleted, leads to an increase in de novo cholesterol synthesis to restore membrane content. Background Recent studies have identified alterations in cholesterol processing associated with cystic fibrosis (CF) [1-4]. The hypothesis of this study is that plasma membrane cholesterol accessibility as measured by electrochemical detection will correlate with CFTR genotype. Identifying this relationship between this cholesterol measurement and CFTR will help determine if this measurement can be

[1]  J. Riordan,et al.  Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[2]  P. Barnes,et al.  The cytokine network in chronic obstructive pulmonary disease. , 2009, American journal of respiratory cell and molecular biology.

[3]  Mustafa Ozen,et al.  Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer , 2009, Clinical Cancer Research.

[4]  T. Murphy,et al.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[5]  N. White,et al.  cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[6]  T. Ha,et al.  Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. , 2008, Biochemical and biophysical research communications.

[7]  T. Goldmann,et al.  TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens , 2008, Diagnostic Pathology.

[8]  R. Strieter What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. , 2008, Proceedings of the American Thoracic Society.

[9]  T. Kelley,et al.  Electrochemical analysis of cell plasma membrane cholesterol at the airway surface of mouse trachea. , 2008, Analytical chemistry.

[10]  R. Stockley,et al.  The interaction of host and pathogen factors in chronic obstructive pulmonary disease exacerbations and their role in tissue damage. , 2007, Proceedings of the American Thoracic Society.

[11]  Jonathan D. Smith,et al.  Direct electrochemical evaluation of plasma membrane cholesterol in live mammalian cells. , 2007, Journal of the American Chemical Society.

[12]  B. Grant,et al.  Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[13]  Y. Lan,et al.  The TGF‐β pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival , 2007, Genesis.

[14]  E. Mazzon,et al.  Protective effect of orally administered carnosine on bleomycin-induced lung injury. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[15]  T. Goldmann,et al.  Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[16]  N. White,et al.  Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[17]  A. Verkman,et al.  CFTR inhibition mimics the cystic fibrosis inflammatory profile. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[18]  A. Churg,et al.  Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. , 2006, American journal of respiratory and critical care medicine.

[19]  D. Warburton,et al.  Smad3 signaling involved in pulmonary fibrosis and emphysema. , 2006, Proceedings of the American Thoracic Society.

[20]  D. Sheppard,et al.  Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. , 2006, Proceedings of the American Thoracic Society.

[21]  R. Homer,et al.  Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. , 2006, Proceedings of the American Thoracic Society.

[22]  John R. Riordan,et al.  Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking , 2006, Journal of Cell Science.

[23]  Dechen Jiang,et al.  Enzyme modification of platinum microelectrodes for detection of cholesterol in vesicle lipid bilayer membranes. , 2005, Analytical chemistry.

[24]  T. Flotte,et al.  The Short Apical Membrane Half-life of Rescued ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results from Accelerated Endocytosis of ΔF508-CFTR in Polarized Human Airway Epithelial Cells* , 2005, Journal of Biological Chemistry.

[25]  T. Goldmann,et al.  Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients , 2005, Respiratory research.

[26]  M. Schluchter,et al.  Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[27]  T. Steck,et al.  How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Roberts,et al.  Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis1 , 2004, The Journal of Immunology.

[29]  N. White,et al.  Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. , 2004, American journal of respiratory cell and molecular biology.

[30]  T. Goldmann,et al.  Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. , 2004, FEMS immunology and medical microbiology.

[31]  J. Riordan,et al.  Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. , 2004, Molecular biology of the cell.

[32]  L. Liscum,et al.  The Transport of Low Density Lipoprotein-derived Cholesterol to the Plasma Membrane Is Defective in NPC1 Cells* , 2003, The Journal of Biological Chemistry.

[33]  T. Goldmann,et al.  Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung , 2003, Histochemistry and Cell Biology.

[34]  Hong Yang,et al.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. , 2002, The Journal of clinical investigation.

[35]  M. Broncel,et al.  The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia , 2002, European Journal of Clinical Pharmacology.

[36]  B. Grant,et al.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.

[37]  B. Grant,et al.  Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.

[38]  P. A. Peterson,et al.  Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. , 2000, The American journal of pathology.

[39]  A. Vaughan,et al.  ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. , 2000, Current opinion in lipidology.

[40]  S. Sethi Bacterial infection and the pathogenesis of COPD. , 2000, Chest.

[41]  J. Hasday,et al.  Bacterial endotoxin is an active component of cigarette smoke. , 1999, Chest.

[42]  W. Timens,et al.  Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[43]  P. Davis,et al.  Overexpression of R domain eliminates cAMP-stimulated Cl- secretion in 9/HTEo- cells in culture. , 1996, The American journal of physiology.

[44]  S. Swain,et al.  Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion , 1995, The Journal of experimental medicine.

[45]  E. Bleecker,et al.  Altered cytokine regulation in the lungs of cigarette smokers. , 1994, American journal of respiratory and critical care medicine.

[46]  Michael J. Hartshorn,et al.  Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport , 1990, Nature.

[47]  O. Baskurt,et al.  Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties. , 2007, Clinical hemorheology and microcirculation.

[48]  P. Keeling,et al.  The dinoflagellates Durinskia baltica and Kryptoperidinium foliaceum retain functionally overlapping mitochondria from two evolutionarily distinct lineages , 2007, BMC Evolutionary Biology.

[49]  R. Schwabe,et al.  TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.

[50]  M. Ameloot,et al.  Membrane cholesterol extraction decreases Na+ transport in A6 renal epithelia. , 2006, American journal of physiology. Cell physiology.

[51]  A. Verkman,et al.  In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents. , 2005, Journal of pharmaceutical sciences.

[52]  J. Keski‐Oja,et al.  Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. , 2004, Critical reviews in clinical laboratory sciences.

[53]  T. Akiyama,et al.  Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. , 2004, Biochemical and biophysical research communications.

[54]  H. Scherthan,et al.  HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. , 2001, Pathology, research and practice.

[55]  C. Niehrs,et al.  Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. , 1999, Nature.

[56]  A. Roberts,et al.  Regulation of immune responses by TGF-beta. , 1998, Annual review of immunology.

[57]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.